Cover Image
市場調查報告書

性感染疾病的償付方案分析及性感染疾病的主要檢驗技術(PCR、免疫層析法毛細血管血流檢驗技術、流式細胞技術、其他 - 全球機會分析與產業預測

Std Reimbursement Scenario Analysis And Top Std Testing Technologies (Pcr, Immunochromatographic Capillary Flow Dipstick Technology, Flow Cytometry, and Others) - Global Opportunity Analysis And Industry Forecast, 2014 - 2022

出版商 Allied Market Research 商品編碼 421131
出版日期 內容資訊 英文 32 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
性感染疾病的償付方案分析及性感染疾病的主要檢驗技術(PCR、免疫層析法毛細血管血流檢驗技術、流式細胞技術、其他 - 全球機會分析與產業預測 Std Reimbursement Scenario Analysis And Top Std Testing Technologies (Pcr, Immunochromatographic Capillary Flow Dipstick Technology, Flow Cytometry, and Others) - Global Opportunity Analysis And Industry Forecast, 2014 - 2022
出版日期: 2016年12月01日 內容資訊: 英文 32 Pages
簡介

本報告提供全球性感染疾病市場相關調查,市場趨勢,償付方案,各技術的市場規模與預測等彙整資料。

第1章 簡介

  • 本報告的內容
  • 主要的市場區隔
  • 調查方法

第2章 摘要整理

第3章 償付方案

  • 概要
  • 預防服務的銷售額和編碼 索引

第4章 各技術市場

  • 簡介
    • 市場規模與預測
  • 實驗室檢驗設備
    • 聚合酵素鏈鎖反應(PCR)
    • 免疫層析法毛細血管血流檢驗技術
    • 流式細胞技術
    • 光散亂差
    • 酵素免疫吸附法(ELISA)
  • 就地檢驗設備
    • 手機晶片
    • 微流體
    • 免疫層析法檢驗
    • 迅速診斷套件

圖表

目錄

The market revenue for diagnostic testing of STDs was valued at $107,024 million in 2015, and is projected to reach $190,010 million by 2022, registering a CAGR of 8.5% over the forecast period. Sexually transmitted diseases (STDs) are alternatively known as venereal diseases (VDs) or sexually transmitted infections (STIs). A variety of methods have been employed for diagnosis of STDs, which differ, based on the type of disease. Rising incidence of fatal STDs, increasing implementation of service provider-initiated counseling and testing (PICT) and client-initiated counseling and testing (CICT) and development of novel technologies such as microfluidics and rapid diagnostics kits for the test of HIV at home and collectively drive the growth of STD testing market. However, inadequate infrastructure provisions (such as laboratories, equipment, and consumables for the diagnostic tests), lack of trained laboratory personnel in the geographic locations (for example, West African countries) and stigma associated with voluntary testing can be the major restraints for the market. Nevertheless, global initiatives along with development in healthcare infrastructure will provide platform for the market growth.

Based on technology the market is divided into PCR, immunochromatographic capillary flow dipstick technology, flow cytometery, differential light scattering, enzyme linked immunosorbent assay, rapid diagnostic kits, phone chips, microfluidics, and immunochromatographic tests. The global STD diagnostics testing market is segmented based on the technology used for the disease diagnosis. It covers the revenue associated with the devices, consumables, disposables and the service cost involved in performing the procedure. PCR dominated the world STD testing market by technology in 2015 and it is expected to maintain the trend throughout the study period owing to its use as the final confirmatory test in most of the STDs. Based on location of testing, market is segmented into laboratories and point-of-care (POC). Currently, laboratories perform bulk of the tests and would continue to hold larger share of the market, both in terms of volume and revenue. Microfluidics is expected to be the fastest growing segment throughout the study period growing at a CAGR of 34.2% owing to the ease of use, technological advancements, and quick results.

KEY BENEFITS:

  • In-depth within all the technologies that would provide a clear understanding of current and future trends in the continuous glucose monitoring systems market.
  • Comprehensive analysis of reimbursement scenario that drive and restrict the growth of the continuous glucose monitoring systems market is provided.
  • The report covers detailed quantitative analysis of the current market, and estimations through 2014-2022, which would enable the stakeholders to capitalize on prevailing market opportunities
  • An in-depth analysis of current reimbursement scenario within CGM System market is provided with key market dynamic factors that help in understanding the behaviour of market

KEY MARKET SEGMENTS

MARKET BY TESTING DEVICES

Laboratory Devices:

  • PCR
  • Immunochromatographic Capillary Flow Dipstick Technology
  • Flow Cytometers
  • Differential Light Scattering Machines
  • Enzyme Linked Immunosorbent Assay (ELISA)

POC Testing Devices:

  • Phone Chips
  • Microfluidics
  • Rapid Diagnostic Kits
  • Immunochromatographic Tests

Table of Contents

CHAPTER 1. INTRODUCTION

  • 1.1. REPORT DESCRIPTION
  • 1.2. KEY MARKET SEGMENTS
  • 1.3. RESEARCH METHODOLOGY
    • 1.3.1. Secondary research
    • 1.3.2. Primary research
    • 1.3.3. Analyst tools and models

CHAPTER 2. EXECUTIVE SUMMARY

CHAPTER 3. REIMBURSEMENT SCENARIO

  • 3.1. OVERVIEW
  • 3.2. PREVENTIVE SERVICE BILLING AND CODING REFERENCE

CHAPTER 4. GLOBAL STD TESTING MARKET, BY TECHNOLOGY

  • 4.1. INTRODUCTION
    • 4.1.1. Market size and forecast
  • 4.2. LABORATORY TESTING DEVICES
    • 4.2.1. Polymerase chain reaction (PCR)
      • 4.2.1.1. Market size and forecast
    • 4.2.2. Immunochromatographic capillary flow dipstick technology (Assay)
      • 4.2.2.1. Market size and forecast
    • 4.2.3. Flow cytometry
      • 4.2.3.1. Market size and forecast
    • 4.2.4. Differential light scattering
      • 4.2.4.1. Market size and forecast
    • 4.2.5. Enzyme linked immunosorbent assay (ELISA)
      • 4.2.5.1. Market size and forecast
  • 4.3. POINT-OF-CARE (POC) TESTING DEVICES
    • 4.3.1. Phone Chips
      • 4.3.1.1. Market size and forecast
    • 4.3.2. Microfluidics
      • 4.3.2.1. Market size and forecast
    • 4.3.3. Immunochromatographic tests (ICTs)
      • 4.3.3.1. Market size and forecast
    • 4.3.4. Rapid diagnostic kits
      • 4.3.4.1. Market size and forecast

List of Tables

  • TABLE 1. STD PREVENTIVE SERVICES BY CDC
  • TABLE 2. LIST OF HCPCS/CPT CODES AND ICD-10 DIAGNOSIS CODE
  • TABLE 3. GLOBAL STD TESTING MARKET, BY LOCATION OF TESTING, 2014-2022 ($MILLION)
  • TABLE 4. GLOBAL STD TESTING MARKET, BY TECHNOLOGY, 2014-2022 ($MILLION)
  • TABLE 5. WORLD STD TESTING MARKET FOR PCR, 2014-2022 ($MILLION)
  • TABLE 6. WORLD STD TESTING MARKET FOR IMMUNOCHROMATOGRAPHIC CAPILLARY FLOW DIPSTICK, 2014-2022 ($MILLION)
  • TABLE 7. WORLD STD TESTING MARKET FOR FLOW CYTOMETRY, 2014-2022 ($MILLION)
  • TABLE 8. WORLD STD TESTING MARKET FOR DIFFERENTIAL LIGHT SCATTERING, 2014-2022 ($MILLION)
  • TABLE 9. WORLD STD TESTING MARKET FOR ELISA, 2014-2022 ($MILLION)
  • TABLE 10. TESTING TECHNOLOGIES FOR STDS
  • TABLE 11. WORLD STD TESTING MARKET FOR PHONE CHIPS, 2014-2022 ($MILLION)
  • TABLE 12. WORLD STD TESTING MARKET FOR MICROFLUIDICS, 2014-2022 ($MILLION)
  • TABLE 13. WORLD STD TESTING MARKET FOR IMMUNOCHROMATOGRAPHIC TEST, 2014-2022 ($MILLION)
  • TABLE 14. SEROLOGICAL TEST FOR STDS
  • TABLE 15. WORLD STD TESTING MARKET FOR RAPID DIAGNOSTIC KITS, 2014-2022 ($MILLION)

List of Figures

  • FIGURE 1. WORLD STD TESTING MARKET FOR PCR, 2014-2022 ($MILLION)
  • FIGURE 2. WORLD STD TESTING MARKET FOR IMMUNOCHROMATOGRAPHIC CAPILLARY FLOW DIPSTICK, 2014-2022 ($MILLION)
  • FIGURE 3. WORLD STD TESTING MARKET FOR IMMUNOCHROMATOGRAPHIC CAPILLARY FLOW DIPSTICK, 2014-2022 ($MILLION)
  • FIGURE 4. WORLD STD TESTING MARKET FOR DIFFERENTIAL LIGHT SCATTERING, 2014-2022 ($MILLION)
  • FIGURE 5. WORLD STD TESTING MARKET FOR ELISA, 2014-2022 ($MILLION)
  • FIGURE 6. WORLD STD TESTING MARKET FOR PHONE CHIPS, 2014-2022 ($MILLION)
  • FIGURE 7. WORLD STD TESTING MARKET FOR MICROFLUIDICS, 2014-2022 ($MILLION)
  • FIGURE 8. WORLD STD TESTING MARKET FOR IMMUNOCHROMATOGRAPHIC TEST, 2014-2022 ($MILLION)
  • FIGURE 9. WORLD STD TESTING MARKET FOR RAPID DIAGNOSTIC KITS, 2014-2022 ($MILLION)
Back to Top